Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.

Osafo C, Raji YR, Burke D, Tayo BO, Tiffin N, Moxey-Mims MM, Rasooly RS, Kimmel PL, Ojo A, Adu D, Parekh RS; H3Africa Kidney Disease Research Network Investigators as members of The H3Africa Consortium.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2279-87. doi: 10.2215/CJN.11951214. Epub 2015 Jul 2.

2.

Addressing the global burden of chronic kidney disease through clinical and translational research.

Ojo A.

Trans Am Clin Climatol Assoc. 2014;125:229-43; discussion 243-6. Review.

3.

International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.

Dienemann T, Fujii N, Orlandi P, Nessel L, Furth SL, Hoy WE, Matsuo S, Mayer G, Methven S, Schaefer F, Schaeffner ES, Solá L, Stengel B, Wanner C, Zhang L, Levin A, Eckardt KU, Feldman HI.

BMC Nephrol. 2016 Sep 2;17(1):121. doi: 10.1186/s12882-016-0335-2.

4.

Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network.

Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, Ulasi I, Salako B, Plange-Rhule J, Mengistu Y, Mc'Ligeyo SO, Moturi G, Winkler CA, Moxey-Mims MM, Rasooly RS, Kimmel P, Adu D, Ojo A, Parekh RS; H3Africa Kidney Disease Research Network.

Kidney Int. 2016 Jul;90(1):2-5. doi: 10.1016/j.kint.2015.12.059. No abstract available.

5.

Development of Bioinformatics Infrastructure for Genomics Research.

Mulder NJ, Adebiyi E, Adebiyi M, Adeyemi S, Ahmed A, Ahmed R, Akanle B, Alibi M, Armstrong DL, Aron S, Ashano E, Baichoo S, Benkahla A, Brown DK, Chimusa ER, Fadlelmola FM, Falola D, Fatumo S, Ghedira K, Ghouila A, Hazelhurst S, Isewon I, Jung S, Kassim SK, Kayondo JK, Mbiyavanga M, Meintjes A, Mohammed S, Mosaku A, Moussa A, Muhammd M, Mungloo-Dilmohamud Z, Nashiru O, Odia T, Okafor A, Oladipo O, Osamor V, Oyelade J, Sadki K, Salifu SP, Soyemi J, Panji S, Radouani F, Souiai O, Tastan Bishop Ö; H3ABioNet Consortium, as members of the H3Africa Consortium.

Glob Heart. 2017 Jun;12(2):91-98. doi: 10.1016/j.gheart.2017.01.005. Epub 2017 Mar 13. Review.

6.

The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.

Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U.

Lancet Glob Health. 2014 Mar;2(3):e174-81. doi: 10.1016/S2214-109X(14)70002-6. Epub 2014 Feb 10. Review. Erratum in: Lancet Glob Health. 2014 May;2(5):266.

7.

Improving CKD therapies and care: a National Dialogue.

Kaskel F, Batlle D, Beddhu S, Daugirdas J, Feldman H, Ferris M, Fine L, Freedman BI, Kimmel PL, Flessner MF, Star RA; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2014 Apr;9(4):815-7. doi: 10.2215/CJN.12631213. Epub 2014 Feb 7.

8.

The Fukuoka Kidney disease Registry (FKR) Study: design and methods.

Tanaka S, Ninomiya T, Fujisaki K, Yoshida H, Nagata M, Masutani K, Tokumoto M, Mitsuiki K, Hirakata H, Fujimi S, Kiyohara Y, Kitazono T, Tsuruya K; Fukuoka Kidney disease Registry (FKR) Study Collaboration Group.

Clin Exp Nephrol. 2017 Jun;21(3):465-473. doi: 10.1007/s10157-016-1294-4. Epub 2016 Jun 23.

PMID:
27339444
9.

High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.

Ulasi II, Tzur S, Wasser WG, Shemer R, Kruzel E, Feigin E, Ijoma CK, Onodugo OD, Okoye JU, Arodiwe EB, Ifebunandu NA, Chukwuka CJ, Onyedum CC, Ijoma UN, Nna E, Onuigbo M, Rosset S, Skorecki K.

Nephron Clin Pract. 2013;123(1-2):123-8. doi: 10.1159/000353223. Epub 2013 Jul 13.

PMID:
23860441
10.

Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.

Anyaegbu EI, Shaw AS, Hruska KA, Jain S.

Pediatr Nephrol. 2015 Jun;30(6):983-9. doi: 10.1007/s00467-014-3031-0. Epub 2014 Dec 23.

11.

APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.

Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, Limou S, Sezgin E, Nelson GW, Fogo AB, Goetsch S, Kopp JB, Winkler CA, Naicker S.

J Am Soc Nephrol. 2015 Nov;26(11):2882-90. doi: 10.1681/ASN.2014050469. Epub 2015 Mar 18.

12.

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; ATHENA National Observational HIV Cohort.

J Infect Dis. 2015 Jul 15;212(2):264-74. doi: 10.1093/infdis/jiv026. Epub 2015 Jan 18.

PMID:
25601941
13.

Averting the legacy of kidney disease - Focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):219-26. doi: 10.4103/1319-2442.178201. Review.

14.

Feasibility of a large cohort study in sub-Saharan Africa assessed through a four-country study.

Dalal S, Holmes MD, Laurence C, Bajunirwe F, Guwatudde D, Njelekela M, Adebamowo C, Nankya-Mutyoba J, Chiwanga FS, Volmink J, Ajayi I, Kalyesubula R, Reid TG, Dockery D, Hemenway D, Adami HO.

Glob Health Action. 2015 May 25;8:27422. doi: 10.3402/gha.v8.27422. eCollection 2015.

15.

A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Cerqueira DC, Soares CM, Silva VR, Magalhães JO, Barcelos IP, Duarte MG, Pinheiro SV, Colosimo EA, Simões e Silva AC, Oliveira EA.

Clin J Am Soc Nephrol. 2014 Apr;9(4):728-35. doi: 10.2215/CJN.06630613. Epub 2014 Jan 23.

16.
17.

Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.

Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG, Kakooza-Mwesige A, Ae-Ngibise K, Owusu-Agyei S, Masanja H, Kamuyu G, Odhiambo R, Chengo E, Sander JW, Newton CR; SEEDS group.

Lancet Neurol. 2013 Mar;12(3):253-63. doi: 10.1016/S1474-4422(13)70003-6. Epub 2013 Jan 31.

18.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

19.

Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: a cross sectional study.

Madala ND, Thusi GP, Assounga AG, Naicker S.

BMC Nephrol. 2014 Apr 14;15:61. doi: 10.1186/1471-2369-15-61.

20.

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.

Matsha TE, Kengne AP, Masconi KL, Yako YY, Erasmus RT.

BMC Genet. 2015 Jun 26;16:69. doi: 10.1186/s12863-015-0228-6.

Supplemental Content

Support Center